Zocor/Simvastatin Side Effect Lawsuit
Zocor/Simvastatin Injury Lawsuits. The maximum dosage (80mg) of the cholesterol-lowering drug Zocor (simvastatin) can result in an increased risk of Myopathy, a severe type of muscle injury and Rhabdomyolysis during the first 12 months of treatment as stated in a recent report released June 8, 2011 by the FDA.The defective drug … [Read more...]
Study Sees Diabetes Risk with High-Dose Statins
A new study is providing yet another reason to avoid High-Dose Statins, Zocor. The study, conducted by researchers in the U.K., has found that high doses of statins, including Zocor and its generic equivalent, simvastatin, are associated with an increased risk of diabetes. The same study also found that 80 mg of simvastatin was not … [Read more...]
Public Citizen Say Do Not Use 80mg Zocor
80 mg Zocor May Cause Myopathy. If you use Zocor (simvastatin) 80 mg, the consumer group Public Citizen says you should talk with your doctor about switching to a lower dose or a different medication all together. Public Citizen placed 80 mg Zocor - the highest recommended dose - on its "Do Not Use" list after the U.S. Food … [Read more...]
FDA Restricts Highest Zocor Dose
Patients Face Risk Over Zocor Dose. Patients taking the statin Zocor (simvastatin) should not be given the highest 80 mg dose in their first year of treatment, according to the U.S. Food & Drug Administration (FDA). The agency's review of a clinical trial, as well as an analysis of its adverse even reports prove that … [Read more...]
High Dose of Zocor Linked to Serious Muscle Injury
Zocor Can Cause Serious Muscle Injury. Federal regulators warned today against taking the highest approved dose - 80 mg - of the statin Zocor (simvastatin). According to the Food & Drug Administration (FDA) the high dose has been associated with a higher risk of serious muscle injury, called myopathy, and a disorder called … [Read more...]
Vytorin Makers $41.5M Settlement
Vytorin Makers Class Action Settlement. Vytorin is a combination of Zetia and the statin Zocor. It has been under the microscope since the ENHANCE study was released in January 2008. ENHANCE found that the drug was no better than a cheaper, generic statin in preventing clogged arteries, and raised serious questions about … [Read more...]
Muscle Weakness Triggered by Zocor
Muscle Weakness Triggered by Zocor. British researchers have just announced yesterday that they have located a gene responsible for muscle pain or weakness that is experienced by some people who are taking the statin drug Zocor. Statins fight "bad" cholesterol. This new finding could lead to routine testing to identify those … [Read more...]
FDA Issues Vytorin Early Communication
FDA Reviews Vytorin. The Food & Drug Administration (FDA) weighed in on the Vytorin controversy today by issuing an Early Communication about its ongoing reviews of Vytorin, Zetia and Zocor. The FDA communication was prompted by preliminary results of the ENHANCE study that showed Vytorin was no better at preventing plaque … [Read more...]
